Reactive hepatitis in a patient with Crohn's disease succcessfully treated with infliximab: Does tumor necrosis factor alpha play a role in reactive hepatitis? [8]

Inflammatory Bowel Diseases

Volumn 11, Issue 1, 2005, Pages 88-90

  Magro, F ^a   Pereira, P ^a   Carneiro, F ^b   Tavarela Veloso, F ^b  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AZATHIOPRINE; GAMMA GLUTAMYLTRANSFERASE; INFLIXIMAB; MESALAZINE; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA; GASTROINTESTINAL AGENT; MONOCLONAL ANTIBODY;

ABDOMINAL PAIN; ADULT; CASE REPORT; COLONOSCOPY; CROHN DISEASE; DIAGNOSTIC IMAGING; DIARRHEA; DRUG EFFICACY; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LETTER; LIVER BIOPSY; LIVER FUNCTION TEST; OUTCOMES RESEARCH; PRIORITY JOURNAL; RELAPSE; WEIGHT REDUCTION; IMMUNOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; CROHN DISEASE; FEMALE; GASTROINTESTINAL AGENTS; HEPATITIS; HUMANS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 13944265036     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200501000-00021     Document Type: Letter

References (10)

1. William F. Balistreri. Hepatobiliary complications of inflammatory bowel disease: overview of the issues. Inflamm Bowel Dis 1998;3:220-224.
2. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet. 1980;1:514-515.
3. Wewer V, Gluud C, Schlichting P, et al. Prevalence of hepatobiliary dysfunction in a regional group of patients with chronic inflammatory bowel disease. Scand J Gastroenterol. 1991; 26:97-102.
4. Broome U, Glaumann H, Hellers G, et al. Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm. Gut. 1994;35:84-89.
5. Mammaev SN, Lukina EA, Shul'pekova LuO, et al. Cytokine regulation of liver inflammation and fibrosis during chronic hepatic diseases. Klin Lab Diagn. 2001;37-40.
6. Neuman M, Angulo P, Malkiewicz I, et al. Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis. J Gastroenterol Hepatol. 2002;17:196-202.
7. Nanji AA. Role of Kupffer cells in alcoholic hepatitis. Alcohol. 2002;27:13-15.
8. Limuro Y, Gallucci RM, Luster MI, et al. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in rat. Hepatology. 1997;26:1530-1537.
9. Campbell S, Ghosh S. Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection. Eur J Gastroenterol Hepatol. 2002;13:191-192.
10. Holtmann M, Galle P, Neurath M. Treatment of patients with Crohn's disease and concomitant chronic hepatitis C with a chimeric monoclonal antibody to TNF. Am J Gastroenterol. 2003;98:504-505.